Gastrointestinal Side Effects of Lithium
Lithium commonly causes gastrointestinal side effects including nausea, vomiting, diarrhea, and abdominal discomfort, which are among the most frequent adverse effects reported during therapy. 1
Primary Gastrointestinal Effects
The FDA-approved drug label explicitly lists the following gastric and GI side effects 1:
- Nausea - appears as a common side effect, particularly during initial therapy
- Vomiting - can occur as both an early sign of toxicity and as a general side effect
- Diarrhea - frequently reported and may indicate early lithium toxicity when serum levels approach 2 mEq/L
- Anorexia - loss of appetite is documented
- Abdominal discomfort - general GI distress may occur
Timing and Clinical Context
Transient and mild nausea and general discomfort typically appear during the first few days of lithium administration. 1 These early-phase symptoms usually subside with continued treatment or temporary dose reduction. 1
Research confirms that postprandial administration of lithium produces practically no side effects, while lithium taken on an empty stomach causes diarrhea in approximately 20% of subjects. 2 This finding has important practical implications for minimizing GI distress.
Toxicity-Related GI Symptoms
Diarrhea and vomiting serve as early warning signs of lithium toxicity and can occur at lithium levels below 2 mEq/L. 1 When these symptoms appear alongside drowsiness, muscular weakness, and lack of coordination, they may indicate developing toxicity requiring immediate medical attention. 1
The FDA label emphasizes that patients must discontinue lithium therapy and contact their physician if clinical signs of toxicity including diarrhea, vomiting, tremor, mild ataxia, drowsiness, or muscular weakness occur. 1
Management Strategies
Lithium should preferably be administered after meals to minimize gastrointestinal side effects. 2 Studies demonstrate complete absorption when given after food, whereas empty-stomach administration results in lower absorption in some subjects due to rapid gastrointestinal passage associated with diarrhea. 2
For persistent GI symptoms 1:
- Temporary dose reduction may alleviate symptoms while maintaining therapeutic benefit
- Cessation of dosage is indicated if symptoms persist despite dose adjustment
- Slow-release formulations may reduce peak-related GI distress
Pediatric Considerations
In pediatric populations, vomiting, headache, and stomachache were the most common side effects in both lithium and placebo groups, though more patients experienced these effects in the lithium group. 3 This suggests both medication-specific and non-specific GI complaints occur in children receiving lithium therapy.
Additional Gastrointestinal Effects
Beyond the primary symptoms, the FDA label documents 1:
- Metallic taste - particularly noted with structurally similar compounds like ethionamide 4
- Dry mouth - listed as an autonomic nervous system effect 1
Clinical Monitoring
Protracted diarrhea can lead to decreased lithium tolerance due to sodium depletion. 1 When diarrhea occurs, supplemental fluid and salt should be administered, as lithium decreases sodium reabsorption by renal tubules. 1